Comparing Sevoflurane Options: Specifications, Materials and Supplier Documentation

Introduction

Sevoflurane (1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy) propane; CAS 28523-86-6; molecular formula C₄H₃F₇O; molecular weight 200.055 g/mol) is a halogenated ether used globally as an inhaled anesthetic for the induction and maintenance of general anesthesia in both adult and pediatric patients. Shijiazhuang Kunxiangda Technology Co., Ltd. lists Sevoflurane across multiple product pages, two of which — the High Purity Sevoflurane API Manufacturers China Suppliers Factory listing and the High Purity Sevoflurane API China Suppliers and Factory for General Anesthesia listing — provide sufficiently detailed and independently documented information for a structured side-by-side comparison.

This comparison is bounded to procurement-relevant documentation criteria: what each listing discloses about the substance's identity, the regulatory standards it references, its stated application scope, its material compatibility notes, and the supply-chain and quality assurance details it offers. Neither listing's claims have been independently verified; this article presents them in parallel so buyers can assess documentation completeness before proceeding with due diligence.

Subjects Under Comparison

Both listings are supplied by Shijiazhuang Kunxiangda Technology Co., Ltd.

Criterion 1: Chemical Identity and Physical-Chemical Parameters

Both listings document the same core identity and share an identical set of physical-chemical values, as shown below.

Notable difference: Listing B additionally states that Sevoflurane is "miscible with ethanol, ether, chloroform, and benzene" in its solubility entry, whereas Listing A's published parameters note only that the substance is insoluble in water, without enumerating organic co-solvents. Listing A's description confirms the same miscibility information in its narrative text, but Listing B surfaces it directly in the formal parameters table.

Chemical name: Listing B explicitly lists the IUPAC-style chemical name (1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy) propane) as a dedicated parameters row; Listing A does not include this field in its parameters table.

Criterion 2: Compliance Standards and Regulatory References

Both listings reference overlapping pharmacopoeial and manufacturing standards, with minor differences in how those references are presented.

Observation: Listing B's published excerpt explicitly mentions CP (Chinese Pharmacopeia) alongside USP and EP. Listing A's published excerpt references USP and EP but does not include CP in the excerpted text for this page. Buyers requiring CP documentation should confirm directly with the supplier which listing's documentation package covers that standard.

Criterion 3: Application Scope

Both listings describe Sevoflurane as suitable for the induction and maintenance of general anesthesia in adult and pediatric patients across inpatient and outpatient surgical settings.

Note: The general catalog product entry (ref-1) contains detailed obstetric anesthesia application notes, including timing, concentration, and procedural precautions relating to maternal and infant safety. Neither dedicated supplier listing (Listing A or Listing B) reproduces this specific clinical guidance in the excerpted text; buyers with obstetric-use requirements should request the full product documentation accordingly.

Criterion 4: Material Compatibility

Both listings document that Sevoflurane is non-corrosive to a range of surgical-grade metals and equipment materials.

Observation: The detailed enumeration of chrome-plated brass and copper beryllium compatibility appears in the general catalog material (ref-1) rather than in either dedicated listing. Both Listing A and Listing B confirm compatibility with stainless steel, aluminum, brass, and nickel-plated components. Equipment procurement teams requiring compatibility with chrome-plated or copper beryllium components should verify against the full technical data sheet.

Criterion 5: Supply-Chain and Quality Assurance Documentation

Observation: Listing A explicitly includes a "Technical Support" point describing vaporization calibration guidance, which does not appear as a separate enumerated item in Listing B's documentation section. Listing B, by contrast, lists "Precision Vaporization" compatibility as its own management platform line, emphasizing calibrated-device delivery. Both address logistics for hazardous/volatile pharmaceutical chemicals, though the phrasing differs slightly. Neither listing specifies minimum order quantities, lead times, or pricing in the approved excerpts.

Summary Comparison Table

Buyer Considerations

For procurement teams comparing these two Sevoflurane listings from Shijiazhuang Kunxiangda Technology Co., Ltd., the differences are primarily in the level of detail and the specific fields each listing surfaces:

• Regulatory documentation completeness: Buyers requiring CP documentation alongside USP/EP coverage should note that CP is explicitly cited in the Listing B excerpt. Confirmation of which documentation package is available for each listing remains the buyer's due diligence step.
• Parameters detail: Listing B includes the IUPAC chemical name and organic solvent miscibility directly in its parameters table, which may be relevant for formulation and compatibility review.
• Technical support framing: Listing A references vaporization calibration and dosage guidance explicitly, which may be relevant for buyers integrating Sevoflurane into clinical delivery systems for the first time.
• Operating conditions: Both listings confirm use only with specialized, calibrated vaporizers and by personnel trained in general anesthesia. Neither listing provides specific dosing protocols; buyers should consult full clinical documentation and applicable pharmacopoeial monographs.

For product inquiries, contact Shijiazhuang Kunxiangda Technology Co., Ltd. directly through the relevant product pages.